Real-time clinical trial information now available on-line

November 01, 2000

NEW YORK, November 2, 2000 - Information about clinical trials - which test new approaches to preventing, diagnosing or treating disease in people - is in demand by cancer patients and their family members who are gaining access to health and medical information through the Internet at unprecedented numbers. In response to that demand, Memorial Sloan-Kettering Cancer Center today launched a lay language database of high priority trials for its web site.

"The information presented on our web site is continually updated with current data from our in-house clinical trial database and includes summaries of each study's purpose, methods and eligibility criteria, written in easy to understand language," says Roger Wilson, MD, Chairman of the Institutional Review Board at Memorial Sloan-Kettering Cancer Center.

The new clinical trials section of Memorial Sloan-Kettering's web site includes a listing of select studies actively enrolling patients at the Center, and provides clear descriptions about each trial's objective, methods and requirements for participation, as well as contact information for the clinical investigator leading the study. The web site is automatically updated whenever the status of a study changes.

"Because the World Wide Web is an evolving medium, it is important for us to make sure new content is added - and existing content is updated - on a real-time basis," says Dr. Wilson. "At the same time, we wanted the information to be easily understandable to patients and members of the public," he adds.

Information about Memorial Sloan-Kettering's open trials has not been previously available in straightforward language that is easily grasped by individuals who do not have a medical background. This new, user-friendly section on the site allows the general public to easily navigate through the browser and identify the trials that are of interest to them.

In addition, a link is provided to the National Institutes of Health clinical trial database, where individuals can get additional information on cancer-related research studies being conducted at Memorial Sloan-Kettering and at other institutions in the United States. Individuals may also call a national, toll-free telephone number (1-800-525-2225), which is available to assist anyone who wishes to see a physician or join a clinical trial at Memorial Sloan-Kettering Cancer Center.

Launched in 1996, Memorial Sloan-Kettering Cancer Center's web site offers comprehensive information on cancer prevention, diagnosis and treatment, as well as detailed descriptions of the Center's broad range of services, facilities and staff. The site is designed to be a source of high quality information that is useful for patients, medical professionals and researchers alike. In 2000 alone, the site has recorded more than 1.4 million user sessions averaging about 10 minutes per session. About 5 to 10 percent of the site's visitors access the web site from overseas on any given day.

Another well-received on-line feature of the site is Lately@MSKCC, a free, monthly electronic newsletter delivered to more than 14,000 subscribers. The newsletter, which was introduced in 1997, offers information on cancer-related topics and updates readers on what is new at the Center - from newly published research to upcoming educational lectures on cancer and live chats during which users can log on and ask questions of Memorial Sloan-Kettering physicians.

The web site also serves as an umbrella for the Sloan-Kettering Institute's web site, where researchers can share information with the scientific community about their work in the lab. Memorial Sloan-Kettering's web site is located at www.mskcc.org.
-end-
Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research and education in cancer. Throughout its long and distinguished history, the Center has played a leadership role in defining the standard of care for patients with cancer.

Memorial Sloan Kettering Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.